Abstract: An efficient synthesis of [3-
probe of a common intermediate used in the synthesis of a number of biologically relevant molecules, has been achieved in 9 steps from an acyclic, non-aromatic precursor. A 13 C label for molecular imaging was introduced in a linear synthesis from the reaction of [ 13 C]-labelled methyl iodide with glutaric monomethyl ester chloride.
Cyclisation then aromatisation gave 1,3-dimethoxybenzene and an additional methoxy group was introduced by a formylation/Baeyer-Villiger/hydrolysis/methylation sequence. Subsequent ortho-formylation and selective demethylation yielded the desired [3- 13 C]-2,3-dihydroxy-4-methoxybenzaldehyde.
Keywords: Dynamic Nuclear Polarisation; properties, thalimonine 5 is a natural product that has shown to be active against influenza and herpes simplex virus, 6-8 whilst stenocepflavone 6 exhibits significant inhibitory activity against acetylcholinesterase, butyrylcholinesterase and lipoxygenases, 9 and 2'-hydroxy-3',4',3,4-tetramethoxychalcone 7 shows a topical antiinflammatory effect in mice. 10 Whilst the biological activity of such compounds is usually easy to obtain, realtime molecular imaging can provide vital information on molecular targets and the metabolic fates of 13 C samples, the relative sensitivity is further increased, allowing in vivo metabolism to be investigated.
Figure 1. Potential natural products derived from key intermediate 1
The design criteria for a 13 C labelled probe for use in DNP studies is critical, since this needs to be at a site in the molecule with a long T 1 relaxation time (essential for extending the lifetime of hyperpolarization), ideally on a quaternary centre remote from any neighboring spin ½ nuclei, which cannot undergo any destructive metabolism that would remove the label from the probe. Furthermore, the label need to be located at a site where metabolic activity occurs in order to observe a change in the chemical shift of the enhanced 13 C signal that would be indicative of any new metabolite formed. For example, combretastatin A1P 2 is known to metabolise into ortho-quinone species 8 and 9 in vivo (Scheme 1), but the biological role of this metabolite has not yet been established. 12 The chemical shift of the highlighted 13 yield via an intramolecular Claisen reaction using potassium tert-butoxide as the base. The product was observed as a mixture of both keto and enol tautomers in the 1 H NMR spectrum. Aromatisation of [2-13 C]-cyclohexane-1,3-dione 12 to give [2-13 C]-resorcinol has previously been achieved by catalytic dehydrogenation using Pd/C in refluxing xylene or triglyme with yields ranging from 45 -88%. [16] [17] [18] However, an alternate, more efficient route was developed that encompassed both the aromatisation and subsequent methylation steps in a one-pot reaction. Thus, dione 12 was heated at reflux with iodine in methanol to give the aromatised 1,3-dimethoxy-[2-13 C]-benzene 13 in 67% yield. 19 Next, the regioselective addition of a hydroxyl group in the 2-position was accomplished using a three-step strategy. Regioselective lithiation of 1,3-dimethoxy-[2-13 C]-5 benzene 13 with nBuLi at 0 °C in the presence of N,N,N ,N -tetramethylethylenediamine followed by treatment with dimethylformamide and gave [1-13 C]-2,6-dimethoxybenzaldehyde 14 in 89% yield. 20 This was then treated with hydrogen peroxide in methanol to affect a Baeyer-Villiger reaction but unfortunately this failed to yield the desired formate ester, instead giving carboxylic acid 15 in a 2:1 ratio with starting material, formed by hydridemigration in the rearrangement step of the Baeyer-Villiger reaction. However, when aldehyde 14 was treated with mCPBA, the desired formate ester was formed, which was hydrolyzed using potassium hydroxide to give phenol 16 in 84% yield over the three-steps from methyl ether 13. 
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In summary, we have adapted and developed an efficient route to install a 13 C label at a strategically important site of a common intermediate that can be used to construct a number of biologically relevant molecules.
Ongoing work is looking to exemplify the use of such an intermediate in the synthesis of the target molecules illustrated.
